Goldberg K., Norman R., Hoch J., Schmitz N., Windell D., Brown T., Malla A. (2006). Impact of a specialized early intervention service for psychotic disorders on patient characteristics, service use, and hospital costs in a defined catchment area, Can J Psychiatry, 51(14), 895-903.

Grizenko N., Bhat M., Schwartz G., Ter-Stepanian M., Joober R. (2006). Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial, J Psychiatry Neurosci, 31(1), 46-51.

Grizenko N., Kovacina B., Amor L. B., Schwartz G., Ter-Stepanian M., Joober R. (2006). Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families, J Am Acad Child Adolesc Psychiatry, 45(1), 47-53.

Gruber R., Brouillette R.T. (2006). Towards an understanding of sleep problems in childhood depression, Sleep, 29(4), 418-20.

Gruber R., Grizenko N., Schwartz G., Ben Amor L., Gauthier S., de Guzman R., Joober R. (2006). Sleep and COMT Polymorphism in ADHD Children: Preliminary Actigraphic Data, J Am Acad Child Adolesc Psychiatry, 45(8), 982-9.

Jensen J. E., Miller J., Williamson P. C., Neufeld R. W., Menon R. S., Malla A., Manchanda R., Schaefer B., Densmore M., Drost D. J. (2006). Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla, Psychiatry Res, 146(2), 127-35.

Joober R., Grizenko N., Sengupta S., Amor L. B., Schmitz N., Schwartz G., Karama S., Lageix P., Fathalli F., Torkaman-Zehi A., Stepanian M. T. (2006). Dopamine Transporter 3'-UTR VNTR Genotype and ADHD: a Pharmaco-Behavioural Genetic Study with Methylphenidate, Neuropsychopharmacology.

Joober R., Schmitz N., Malla A., Sengupta S., Karma S. (2006). Is olanzapine a brain-sparing medication?, Arch Gen Psychiatry, 63(11), 1292.

Joober R., Sengupta S. (2006). Parent-of-Origin Effect and Risk for Attention-Deficit/Hyperactivity Disorder: Balancing the Evidence against Bias and Chance Findings, Am J Hum Genet, 79(4), 765-6.

Kalynchuk L. E., Pinel J. P., Meaney M. (2006). Serotonin receptor binding and mRNA expression in the hippocampus of fearful amygdala-kindled rats, Neurosci Lett, 396(1), 38-43.

Kopala L., Smith G., Malla A., Williams S., Love L., Talling D., Balshaw R. (2006). Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders, Acta Psychiatr Scand Suppl(430), 29-39.

Leonhardt M., Matthews S. G., Meaney M., Walker C. (2006). Psychological stressors as a model of maternal adversity: Diurnal modulation of corticosterone responses and changes in maternal behavior, Horm Behav.

Lepage M., Montoya A., Pelletier M., Achim A. M., Menear M., Lal S. (2006). Associative Memory Encoding and Recognition in Schizophrenia: An Event-Related fMRI Study, Biol Psychiatry.

Levine Y., Boksa P. (2006). Maternal care is similar for rat pups subjected to birth hypoxia and for controls, Neuroreport, 17(1), 45-9.

Malla A., Norman R. (2006). Preface, Acta Psychiatr Scand Suppl(430), 3.

Malla A., Norman R., Schmitz N., Manchanda R., Bechard-Evans L., Takhar J., Haricharan R. (2006). Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study, Psychol Med, 1-10.

Malla A., Williams S., Kopala L., Smith G., Talling D., Balshaw R. (2006). Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders, Acta Psychiatr Scand Suppl(430), 22-8.

Montoya A., Pelletier M., Menear M., Duplessis E., Richer F., Lepage M. (2006). Episodic memory impairment in Huntington's disease: A meta-analysis, Neuropsychologia, 44(10), 1984-94.

Montoya A., Price B. H., Menear M., Lepage M. (2006). Brain imaging and cognitive dysfunctions in Huntington's disease, J Psychiatry Neurosci, 31(1), 21-9.

Payne J., Malla A., Norman R., Windell D., Nicole B. (2006). Status of first-episode psychosis patients presenting for routine care in a defined catchment area, Can J Psychiatry, 51(1), 42-7.